These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23088940)

  • 21. Sequential administration of alendronate and strontium ranelate: histomorphometry and bone biomechanics in ovariectomized animals.
    Díaz DH; Rodas JA; Bozzini CE; Mandalunis PM; Escudero ND
    Acta Odontol Latinoam; 2016 Sep; 29(2):168-177. PubMed ID: 27731487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury.
    Si X; Liu X; Li J; Wu X
    Int J Clin Exp Pathol; 2015; 8(10):12368-78. PubMed ID: 26722423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening.
    Aspenberg P; Agholme F; Magnusson P; Fahlgren A
    Bone; 2011 Feb; 48(2):225-30. PubMed ID: 20858557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats.
    Sato M; Bryant HU; Iversen P; Helterbrand J; Smietana F; Bemis K; Higgs R; Turner CH; Owan I; Takano Y; Burr DB
    J Pharmacol Exp Ther; 1996 Oct; 279(1):298-305. PubMed ID: 8859007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Odanacatib Restores Trabecular Bone of Skeletally Mature Female Rabbits With Osteopenia but Induces Brittleness of Cortical Bone: A Comparative Study of the Investigational Drug With PTH, Estrogen, and Alendronate.
    Khan MP; Singh AK; Singh AK; Shrivastava P; Tiwari MC; Nagar GK; Bora HK; Parameswaran V; Sanyal S; Bellare JR; Chattopadhyay N
    J Bone Miner Res; 2016 Mar; 31(3):615-29. PubMed ID: 26391310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alendronate prevents bone loss and improves tendon-to-bone repair strength in a canine model.
    Thomopoulos S; Matsuzaki H; Zaegel M; Gelberman RH; Silva MJ
    J Orthop Res; 2007 Apr; 25(4):473-9. PubMed ID: 17205555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic treatment with angiotensin AT1 receptor antagonists reduced serum but not bone TGF-beta1 levels in ovariectomized rats.
    Li YQ; Ji H; Shen Y; Ding LJ; Zhuang P; Yang YL; Huang QJ
    Can J Physiol Pharmacol; 2009 Jan; 87(1):51-5. PubMed ID: 19142215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Acupoint Application Therapy with TianGui Powder on Osteoporosis in Ovariectomized Rats through TGF-β1 and Smad2/3 Signaling Pathway.
    Lin XS; Wang HY; Zhang Z; Liu HJ; Qu Z; Wu KL; Xiao QH; Zhu JZ; Zhang P
    Orthop Surg; 2019 Feb; 11(1):143-150. PubMed ID: 30834706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen and alendronate therapies may prevent the influence of estrogen deficiency on the tooth-supporting alveolar bone: a histometric study in rats.
    Duarte PM; Gonçalves P; Casati MZ; de Toledo S; Sallum EA; Nociti FH
    J Periodontal Res; 2006 Dec; 41(6):541-6. PubMed ID: 17076779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. μCT-based, in vivo dynamic bone histomorphometry allows 3D evaluation of the early responses of bone resorption and formation to PTH and alendronate combination therapy.
    de Bakker CM; Altman AR; Tseng WJ; Tribble MB; Li C; Chandra A; Qin L; Liu XS
    Bone; 2015 Apr; 73():198-207. PubMed ID: 25554598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the effects of photobiomodulation on vertebras in two rat models of experimental osteoporosis.
    Fredoni M; Ghatrehsamani M; Abdollahifar MA; Bayat S; Bayat M
    Lasers Med Sci; 2017 Sep; 32(7):1545-1560. PubMed ID: 28725994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of estrogen deficiency on cortical bone microporosity and mineralization.
    Sharma D; Larriera AI; Palacio-Mancheno PE; Gatti V; Fritton JC; Bromage TG; Cardoso L; Doty SB; Fritton SP
    Bone; 2018 May; 110():1-10. PubMed ID: 29357314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.
    Yao W; Tian XY; Chen J; Setterberg RB; Lundy MW; Chmielzwski P; Froman CA; Jee WS
    J Musculoskelet Neuronal Interact; 2007; 7(2):119-30. PubMed ID: 17627081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo toxicity of 5-FdU-alendronate, a novel cytotoxic bone-seeking duplex drug against bone metastasis.
    Schott S; Vallet S; Tower RJ; Noor S; Tiwari S; Schem C; Busch C
    Invest New Drugs; 2015 Aug; 33(4):816-26. PubMed ID: 25986684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor-beta1 promotes articular cartilage repair through canonical Smad and Hippo pathways in bone mesenchymal stem cells.
    Ying J; Wang P; Zhang S; Xu T; Zhang L; Dong R; Xu S; Tong P; Wu C; Jin H
    Life Sci; 2018 Jan; 192():84-90. PubMed ID: 29158053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alendronate administration and skeletal response during chronic alcohol intake in the adolescent male rat.
    Wezeman FH; Emanuele MA; Moskal SF; Steiner J; Lapaglia N
    J Bone Miner Res; 2000 Oct; 15(10):2033-41. PubMed ID: 11028458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
    Gasser JA; Ingold P; Venturiere A; Shen V; Green JR
    J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the effects of LLLT on biomechanical properties of tibial diaphysis in two rat models of experimental osteoporosis by a three point bending test.
    Fridoni M; Masteri Farahani R; Nejati H; Salimi M; Gharavi SM; Bayat M; Amini A; Torkman G; Bayat S
    Lasers Med Sci; 2015 Apr; 30(3):1117-25. PubMed ID: 25616711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologically Inactive Bisphosphonates as an Alternative Strategy for Targeting Osteoclasts: In Vivo Assessment of 5-Fluorodeoxyuridine-Alendronate in a Preclinical Model of Breast Cancer Bone Metastases.
    Schem C; Tower RJ; Kneissl P; Rambow AC; Campbell GM; Desel C; Damm T; Heilmann T; Fuchs S; Zuhayra M; Trauzold A; Glüer CC; Schott S; Tiwari S
    J Bone Miner Res; 2017 Mar; 32(3):536-548. PubMed ID: 27714838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.